Wells Fargo’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,800
Closed -$963 6723
2024
Q4
$963 Hold
1,800
﹤0.01% 5756
2024
Q3
$3.17K Buy
+1,800
New +$3.17K ﹤0.01% 5591
2024
Q2
Sell
-16,374
Closed -$148K 7177
2024
Q1
$148K Buy
16,374
+2,430
+17% +$22K ﹤0.01% 4296
2023
Q4
$152K Buy
13,944
+3,273
+31% +$35.6K ﹤0.01% 4245
2023
Q3
$85.9K Sell
10,671
-10,096
-49% -$81.3K ﹤0.01% 4531
2023
Q2
$226K Buy
20,767
+20,455
+6,556% +$222K ﹤0.01% 4275
2023
Q1
$2.15K Buy
312
+16
+5% +$110 ﹤0.01% 5892
2022
Q4
$1.18K Buy
296
+71
+32% +$283 ﹤0.01% 5810
2022
Q3
$1K Buy
225
+4
+2% +$18 ﹤0.01% 6181
2022
Q2
$1K Sell
221
-4,647
-95% -$21K ﹤0.01% 6361
2022
Q1
$46K Sell
4,868
-13,191
-73% -$125K ﹤0.01% 5370
2021
Q4
$214K Buy
18,059
+17,858
+8,885% +$212K ﹤0.01% 4864
2021
Q3
$2K Hold
201
﹤0.01% 6275
2021
Q2
$3K Sell
201
-5,768
-97% -$86.1K ﹤0.01% 6149
2021
Q1
$92K Sell
5,969
-18,033
-75% -$278K ﹤0.01% 5181
2020
Q4
$293K Buy
24,002
+1,299
+6% +$15.9K ﹤0.01% 4778
2020
Q3
$292K Sell
22,703
-2,384
-10% -$30.7K ﹤0.01% 4594
2020
Q2
$256K Buy
25,087
+10,425
+71% +$106K ﹤0.01% 4616
2020
Q1
$118K Buy
14,662
+1,800
+14% +$14.5K ﹤0.01% 4791
2019
Q4
$111K Sell
12,862
-1,994
-13% -$17.2K ﹤0.01% 5048
2019
Q3
$91K Buy
14,856
+1,695
+13% +$10.4K ﹤0.01% 5122
2019
Q2
$218K Buy
13,161
+8,768
+200% +$145K ﹤0.01% 4758
2019
Q1
$73K Sell
4,393
-13
-0.3% -$216 ﹤0.01% 5140
2018
Q4
$51K Sell
4,406
-33
-0.7% -$382 ﹤0.01% 5228
2018
Q3
$178K Buy
4,439
+3,324
+298% +$133K ﹤0.01% 4878
2018
Q2
$32K Sell
1,115
-5,984
-84% -$172K ﹤0.01% 5418
2018
Q1
$108K Buy
7,099
+218
+3% +$3.32K ﹤0.01% 5038
2017
Q4
$225K Buy
+6,881
New +$225K ﹤0.01% 4734
2016
Q3
Sell
-125
Closed -$1K 5990
2016
Q2
$1K Hold
125
﹤0.01% 5706
2016
Q1
$3K Buy
125
+100
+400% +$2.4K ﹤0.01% 5706
2015
Q4
$1K Hold
25
﹤0.01% 5802
2015
Q3
$1K Sell
25
-175
-88% -$7K ﹤0.01% 5780
2015
Q2
$9K Buy
+200
New +$9K ﹤0.01% 5600